Research into skin cancer, skin disease in the immunosuppressed and male genital dermatoses
Dr Goolamali is a Consultant Dermatologist at the Royal Berkshire Hospital in Reading. He graduated from Imperial College School of Medicine, London in 2000. He underwent his training in Dermatology in London, initially at Chelsea and Westminster Hospital (C&W), before becoming a Specialist registrar at King’s College Hospital and the St John’s Institute of Dermatology at St Thomas’ Hospital. On completing specialist training in 2010, he was appointed to Chelsea and Westminster Hospital as a Senior Dermatology Clinical Research Fellow. Through national, open and peer-reviewed competition, he was awarded the prestigious British Skin Foundation research fellowship (2010-2012). He has undertaken research as part of an MD under the auspices of Imperial College looking at the role of HPV and immunogenotype in non-melanoma skin cancer/pre-cancer in HIV. This work continued whilst appointed by the C&W Trust as a locum Consultant Dermatologist (2011-2013). This project has been kindly supported by START and we believe the study is the largest of its kind in the world.
Through the awarding of Travel scholarships (including that from the Westminster Medical School Research Trust), the data has been presented at meetings both nationally and internationally. These include the annual HIV Symposium, Queen Mary University of London (2011, 2013, 2015), the annual William Harvey Day at St Bartholomew’s Hospital, London (2011), the British Association of Dermatology Annual Meeting (BAD), Birmingham, (2012), the Society for Investigative Dermatology Annual Meeting (SID), North Carolina, USA (2012), the International Investigative Dermatology Meeting (IID), Edinburgh, UK (2013) and the European Society for Dermatological Research Annual Meeting (ESDR), Venice, Italy (2012), Copenhagen, Denmark (2013) and Rotterdam, The Netherlands (2015).
Without the generous support of START, none of this research would have been possible. The hope is for this research to be ongoing.